VERVE THERAPEUTICS
HQ - Boston
Summary
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 1.11 B
Avg. Deal Size£ 1.11 B
All rights reserved. Copyright © 2025 Datasite
